Scientists have started testing a single vaccine against coronavirus and influenza

November 04, 2022 | 21:46 |8198

Source:

Researchers from the American company Pfizer and the German drug manufacturer BioNTech SE have begun testing a combined vaccine against COVID-19 and influenza, Reuters reports.

Research in this direction marks the beginning of a new stage in the work of pharmaceutical companies and promises significant changes in the global vaccine market.

The first trials of a single vaccine against coronavirus and influenza, based on mRNA technology, began in the United States on 180 volunteers aged 18 to 64 years. Moderna and Novavax are currently working on similar vaccines.

ORIENT news
Photo: reuters.com

Scientists have started testing a single vaccine against coronavirus and influenza

More news

Azerbaijan represented by a special exhibition stand at un day event in Ashgabat

Following Arçalyk: Turkmen Confectionery Brand Kindi Nominated for Awwwards

Rashid Meredov and Maka Bochorishvili coordinate positions ahead of the "Central Asia – Georgia" meeting